Impact of optimism training on atherosclerotic biomarkers in coronary artery disease: A randomized controlled trial

Masoumeh Sadeghi1, Nasim Kakavand1, Mohammadesmaeil Aramesh Boroujeni2

  • 1Cardiac Rehabilitation Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.

PubMed

Insights

Optimism training improved psychological health in cardiac patients but had minimal, uncertain effects on adhesion molecules like ICAM-1 and VCAM-1. Larger studies are needed to confirm clinical significance.

Area of Science:

  • Cardiovascular Medicine
  • Psychoneuroimmunology
  • Biomarker Research

Background:

  • Atherosclerosis, a chronic inflammatory disease, drives cardiovascular disease (CVD) mortality.
  • Intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) are key in atherosclerosis development.
  • The impact of optimism interventions on these adhesion molecules is not well-understood.

Purpose of the Study:

  • To investigate the effect of an optimism-based intervention on ICAM-1 and VCM-1 levels in coronary artery disease (CAD) patients.
  • To assess psychological changes, including depression, anxiety, and negative affect, following the intervention.

Main Methods:

  • A randomized controlled trial with 61 stable CAD patients post-cardiac rehabilitation.
  • An eight-week group-based optimism training program versus an attention-matched control group.
  • Measurement of plasma ICAM-1 and VCAM-1 via ELISA at baseline and 16 weeks; psychological assessments.

Main Results:

  • Optimism intervention significantly reduced depression, anxiety, and negative affect (p < 0.05).
  • Small, inconclusive between-group differences in adhesion molecule levels were observed post-intervention.
  • No significant group-by-time interactions or correlations between optimism changes and adhesion molecule levels.

Conclusions:

  • Optimism interventions offer psychological benefits for CAD patients.
  • Observed changes in adhesion molecule biomarkers (ICAM-1, VCAM-1) were minor and uncertain.
  • Further research with larger sample sizes is necessary to clarify the clinical relevance of these findings due to high biomarker variability.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.1K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
455
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
270
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
374
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
689
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
380